logo

Mallinckrodt Plc (MNK)



Trade MNK now with
  Date
  Headline
8/23/2018 6:45:53 AM Mallinckrodt And NPXe Announce FDA Fast Track Designation For Phase 3 Trial Of Inhaled Xenon Gas Therapy
8/22/2018 6:49:55 AM Mallinckrodt Confirms Complete Response Letter From FDA Related To NDA For Stannsoporfin
8/7/2018 6:06:06 AM Mallinckrodt Q2 Adjusted EPS $1.78 Vs $1.36 Last Year
6/18/2018 6:33:55 AM Mallinckrodt Reports Interim Findings Of H.P. Acthar® Gel Studies
5/8/2018 6:05:41 AM Mallinckrodt Posts Q1 Net Loss Of $18 Mln Or $0.21/share
5/3/2018 6:51:38 PM Mallinckrodt Says FDA Committee Recommend That Risk-benefit Profile Of Stannsoporfin Does Not Support Approval
5/2/2018 2:51:27 PM B. Riley FBR Starts Mallinckrodt plc (MNK) At Neutral With $15 Price Target
4/4/2018 6:26:33 AM Mallinckrodt Nominates Two New Members, Paul Carter And Anne Whitaker, To Its Board
4/4/2018 6:21:18 AM Mallinckrodt: Angus Russell To Succeed Melvin Booth As Chairman Of Board In May 2018
3/19/2018 7:49:31 AM Mallinckrodt Closes Sale Of RECOTHROM And PREVELEAK To Baxter
2/27/2018 6:07:38 AM Mallinckrodt Q4 GAAP EPS From Cont Ops $17.40 Vs Loss $1.67 Last Year